Results 81 to 90 of about 712 (172)

Novel Non-Hallucinogenic Compounds as 5‑HT2A Agonists for Treating Mental Health Disorders, Namely Depression, Anxiety, Stress Disorders, and Eating Disorders. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Psychedelics. [PDF]

Curr Biol, 2022
Kelmendi B, Kaye AP, Pittenger C, Kwan AC.   +3 more
europepmc   +1 more source

ChemInform Abstract: Synthesis of 5(10 → 9)abeo-Ergolines.

, 2010
S. MANTEGANI, M. VARASI, D. BORGHI, E. ARLANDINI, E. BRAMBILLA   +4 more
core   +1 more source

Natural Product-Inspired Dopamine Receptor Ligands. [PDF]

J Med Chem
Dorogan M, Namballa HK, Harding WW.
europepmc   +1 more source

Novel Non-hallucinogenic Neurite Growth Compounds as 5‑HT2A Agonists for Treating Stress-Related Disorders, Namely Depression, Anxiety, and PTSD. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

The working lives of neuronal 5-HT_2A receptors from the outside in. [PDF]

RSC Chem Biol
Jabar A, Pinto M, Hébert TE.
europepmc   +1 more source

A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test. [PDF]

Einstein (Sao Paulo)
Galliano SA, Stumpf MAM, Queiroz NL, Ferreira EHR, Craveiro FL, Gruetzmacher C, Silva GOD, Cescato VAS, Vellutini EAS, Cunha-Neto MBC, Batista RL, Glezer A.   +11 more
europepmc   +1 more source

ChemInform Abstract: OCTAHYDROBENZO(G)QUINOLINES: POTENT DOPAMINE AGONISTS WHICH SHOW THE RELATIONSHIP BETWEEN ERGOLINES AND APOMORPHINE

, 1985
R. NORDMANN, T. I. PETCHER
core   +1 more source

ChemInform Abstract: CONVERSION OF ERGOLINES TO HEXAHYDRO‐ AND OCTAHYDROBENZO(F)QUINOLINES (DEPYRROLOERGOLINES)

, 1980
E. C. KORNFELD, J. A. CLEMENS, E. B. SMALSTIG, N. J. BACH   +3 more
core   +1 more source

Intramolecular Alkylation of Aromatic Compounds. Part 36. Stereoselective Synthesis of C/D‐cis‐Configured Ergolines.

, 2002
Eugen Hargasser, Eberhard Reimann, Hermann Lotte, Wolfgang Erdle   +3 more
core   +1 more source